SCHEMBL20636697

SCHEMBL20636697

CCSc1c(-c2nc3cc(C(F)(F)F)cnc3n2C)nn2cc(Cl)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NCOA2 Q15596 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ STAT3 P40763 1/20 0.34
▸ STAT1 P42224 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20636699 0.92 POLB (0.44) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL19993455 0.83 POLB (0.40) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL23956549 0.82 POLB (0.37) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL19299826 0.78 POLB (0.43) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL19283517 0.78 POLB (0.43) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL10280699 0.77 POLB (0.48) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL16376049 0.77 POLB (0.48) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL29431602 0.77 POLB (0.48) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL22776013 0.77 POLB (0.44) POLBSMN1; SMN2LMNANPSR1XBP1
SCHEMBL18627806 0.76 POLB (0.47) POLBSMN1; SMN2LMNANPSR1XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759815-B2 Condensed heterocyclic compounds and pesticides NISSAN CHEMICAL CORPORATION (JP) 2020-09-01 — — US disclosed
US-20200223868-A1 CONDENSED HETEROCLYCLIC COMPOUNDS AND PESTICIDES NISSAN CHEMICAL CORPORATION (JP) 2020-07-16 — — US disclosed
US-10640518-B2 Condensed heterocyclic compounds and pesticides NISSAN CHEMICAL CORPORATION (JP) 2020-05-05 — — US disclosed
US-20200095263-A1 CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES NISSAN CHEMICAL CORPORATION (JP) 2020-03-26 — — US disclosed
US-10544163-B2 Condensed heterocyclic compounds and pesticides NISSAN CHEMICAL CORPORATION (JP) 2020-01-28 — — US disclosed
EP-3428166-A1 CONDENSED HETEROCYCLIC COMPOUND AND PEST CONTROL AGENT Nissan Chemical Corporation (JP) 2019-01-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10759815-B2 Condensed heterocyclic compounds and pesticides NR4A1, CHRM1, NR1D2 POLB 4343/4885SMN1; SMN2 3946/4885LMNA 2299/4885
US-20200223868-A1 CONDENSED HETEROCLYCLIC COMPOUNDS AND PESTICIDES CHRM1, HCRTR1, NR4A1 POLB 4742/4885SMN1; SMN2 4303/4885LMNA 2180/4885
US-10544163-B2 Condensed heterocyclic compounds and pesticides NR4A1, CHRM1, NR1D2 POLB 4393/4885SMN1; SMN2 3930/4885LMNA 2413/4885
US-20200095263-A1 CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES NR4A1, CHRM1, NR1D2 POLB 4393/4885SMN1; SMN2 3930/4885LMNA 2413/4885
US-10640518-B2 Condensed heterocyclic compounds and pesticides NR4A1, CHRM1, NR1D2 POLB 4297/4885SMN1; SMN2 3966/4885LMNA 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback